AUTOIMMUNE ENCEPHALITIS
Clinical trials for AUTOIMMUNE ENCEPHALITIS explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE ENCEPHALITIS trials appear
Sign up with your email to follow new studies for AUTOIMMUNE ENCEPHALITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of brain disease 'Shield' drug begins
Disease control OngoingThis is the first study in people to test the safety of a new drug called ART5803. It is being tested in 64 healthy volunteers to see how their bodies handle it and to check for side effects. The drug is designed to block harmful antibodies that cause a serious brain inflammation…
Matched conditions: AUTOIMMUNE ENCEPHALITIS
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Doctors track new cell therapies for Hard-to-Treat brain inflammation
Disease control OngoingThis study is observing patients with autoimmune or post-infection brain inflammation who are receiving stem cell or exosome treatments. It aims to track changes in their neurological symptoms, inflammation levels, and quality of life. The goal is to gather information on how wel…
Matched conditions: AUTOIMMUNE ENCEPHALITIS
Sponsor: Biocells Medical • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
First human test for promising brain disease drug begins
Disease control OngoingThis is a very early study to check the safety of a new drug called ART5803 in healthy people. The drug is being developed to treat a serious brain inflammation disease. Researchers want to see how the drug behaves in the body when given after a common treatment called IVIG.
Matched conditions: AUTOIMMUNE ENCEPHALITIS
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC